What's new

Human medicines European public assessment report (EPAR): Doptelet, avatrombopag, Date of authorisation: 20/06/2019, Revision: 10, Status: Authorised

Human medicines European public assessment report (EPAR): Doptelet, avatrombopag, Date of authorisation: 20/06/2019, Revision: 10, Status: Authorised

Jun 18, 2025 - 16:25
 0
Human medicines European public assessment report (EPAR): Doptelet, avatrombopag, Date of authorisation: 20/06/2019, Revision: 10, Status: Authorised
Human medicines European public assessment report (EPAR): Doptelet, avatrombopag, Date of authorisation: 20/06/2019, Revision: 10, Status: Authorised
Read More

Tags:

Previous Article

Human medicines European public assessment report (EPAR): Rezzayo, rezafungin, D...

Next Article

Human medicines European public assessment report (EPAR): Prolia, denosumab, Dat...

Related Posts

EMEA-000639-PIP03-16-M03

EMEA-000639-PIP03-16-M03

May 15, 2025  0

Concept paper on the development of a guideline on cons...

May 23, 2025  0

Human medicines European public assessment report (EPAR): Rozlytrek, entrectinib, Date of authorisation: 31/07/2020, Revision: 11, Status: Authorised

Human medicines European public assessment report (EPAR...

Jun 10, 2025  0